OTS

David Corey, Ph.D. UT Southwestern Medical Center Biography: Dr. Corey received his BA from Harvard in 1985 and his PhD from UC Berkeley in 1990 under the guidance of Dr. Peter Schultz. After postdoctoral study in the laboratory of Dr. Charles Craik at UCSF, ...

Michele Carrer, Ph.D. Executive Director, Department of Neurology Ionis Pharmaceuticals, Carlsbad, CA “Conjugation to a transferrin receptor 1-binding Bicycle peptide enhances ASO and siRNA potency in skeletal and cardiac muscles” https://doi.org/10.1093/nar/gkaf270 Biography: Michele Carrer, Ph.D., is an Executive Director in the Department of Neurology ...

Ken Yamada, Ph.D. RTI, UMass Chan Medical School “Extended Nucleic Acid (exNA): A Novel Platform Technology Development for Enhancing siRNA Potency in Vivo” Paper of the Year: Enhancing siRNA efficacy in vivo with extended nucleic acid backbones https://doi.org/10.1038/s41587-024-02336-7 Biography: Dr. Ken Yamada is an ...

Daniel Knight, PhD Candidate Carleton University “Strengthening Research, Advocacy, and Collaboration in ALS: The Dual Perspective of a Scientist and Community Member” Biography Daniel Knight is a fourth-year PhD candidate in chemistry at Carleton University in Ottawa, Canada, where he is developing a novel ...

Cristina Hofman, PhD Candidate UT Southwestern Medical Center “Nuclear Argonaute:miRNA complexes recognize target sequences within chromatin-associated RNA and silence gene expression” Biography: Cristina received her B.S. in Biochemistry and Molecular Biology at Trinity University and joined David Corey’s lab at the University of Texas ...

Hien Tran Zhao, Ph.D. Ionis Pharmaceuticals, Inc. “Harnessing antisense oligonucleotide for the treatment of neurological disorders” Biography: Dr. Zhao has over 15 years of experience in Neuroscience Drug Discovery. She is currently an Executive Director of Neurology Research at Ionis Pharmaceuticals, Inc., a company ...

Prof. Wojtek Stec (15 October 1940 - 4 December 2024) Biography: An outstanding chemist and a co-founder of Polish phosphorus chemistry of bioorganic compounds, Professor Stec was a distinguished scientific leader and a dedicated mentor. His research interests centered on bioorganic chemistry, with a ...

Brett Monia, Ph.D. Chief Executive Officer, Ionis Pharmaceuticals "Pioneering RNA-Targeted Oligonucleotide Therapeutics: A 35-Year Journey" Biography: Dr. Monia is the chief executive officer, a member of the board of directors and a founding scientist of Ionis Pharmaceuticals. His contributions at Ionis include research into ...

Marc Lemaitre, Ph.D. M_L Consult Biography: Dr. Lemaitre is very experienced with and has an in-depth knowledge of oligonucleotide therapeutics, mainly focusing on Chemistry, Manufacturing and Control [CMC]. He holds a Master’s degree in Organic Chemistry and a Ph.D. in Biochemistry, with extensive training ...

Sarah E. Pierce, Ph.D. Broad Institute “An approach to disease-agnostic therapeutic genome editing” Biography: Sarah Pierce is a postdoctoral fellow in Dr. David Liu's lab at the Broad Institute. She completed her PhD in Cancer Biology at Stanford University in the labs of Dr. ...